MEDICLIN Aktiengesellschaft

MEDICLIN Aktiengesellschaft

5.25
EUR
-0.05
(-0.94%)
0.61EPS
6.43P/E
185.25MMarket Cap
Nov 05Next Earn
MEDICLIN Aktiengesellschaft
GETTEX:MED
(Gettex)

Recent

price

5.25

P/E

ratio

6.43

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
10.26
10.39
10.73
10.84
11.33
11.69
12.22
12.82
13.58
14.17
13.89
14.17
14.84
15.37
15.76
16.52
16.39
Revenue per Share
0.21
0.07
-0.03
-0.06
0.18
0.35
0.35
0.08
0.16
0.2
-0.19
0.03
0.2
-0.23
0.52
0.54
0.61
Basic EPS, GAAP
-0.17
-0.25
-0.18
-0.14
0.26
0.1
0.08
-0.33
-0.39
0.52
1.96
1.37
0.18
0.85
0.76
1.07
1.08
Free Cash Flow per Basic Share
0.05
0.05
- -
- -
- -
- -
- -
- -
0.05
0.05
- -
- -
- -
- -
- -
0.04
- -
Dividend per Share
3.4
3.42
3.31
3.21
3.25
3.57
3.83
3.91
4.03
4.02
3.73
3.86
4.4
4.12
4.68
5.24
5.46
Book Value per Share
2.27
2.32
2.24
2.12
2.19
2.51
2.73
2.75
2.84
2.8
2.51
2.66
3.24
3.64
4.16
4.88
5.1
Tangible Book Value per Share
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
Basic Weighted Avg Shares
487
494
510
515
538
555
580
609
645
673
660
673
705
730
749
785
787
Sales/Revenue/Turnover
3.46
2.4
0.7
0.27
2.73
4.08
3.98
0.94
2.19
3.18
-0.11
1.62
2.61
1.6
6.73
6.69
9.02
Operating Margin (%)
14
17
17
17
19
18
19
20
22
71
77
74
71
86
50
60
61
Depreciation Expense
10
3
-1
-3
9
17
17
4
8
10
-9
1
9
-11
25
25
29
Net Income, GAAP
12.74
47.33
- -
- -
28.44
17.04
20.57
6.95
34.54
16.6
- -
39.28
0.59
- -
22.44
26.41
27.74
Effective Tax Rate (%)
2.07
0.63
-0.28
-0.51
1.58
2.98
2.85
0.64
1.2
1.44
-1.36
0.22
1.34
-1.48
3.32
3.25
3.7
Profit Margin (%)
10
12
47
41
49
56
69
64
61
20
33
53
91
154
132
115
131
Working Capital
11
23
67
61
54
47
46
37
55
441
406
358
452
454
436
362
340
LT Debt
162
162
157
152
154
169
182
185
191
191
177
183
209
196
223
250
260
Total Equity
5.98
2.7
- -
- -
5.19
8.92
8.21
2.57
3.9
3.85
- -
1.09
2.9
- -
6.03
6.02
7.7
Return on Invested Capital (%)
6.13
2.81
- -
- -
5.26
8.92
8.27
2.62
3.92
3.87
- -
1.1
2.95
- -
6.37
6.22
6.65
Return on Capital (%)
6.33
1.93
-0.88
-1.7
5.54
10.21
9.42
2.13
4.09
5.05
-4.89
0.81
4.81
-5.32
11.87
10.81
11.85
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
28
28
28
LT Borrowings
14
- -
- -
LT Finance Leases
349
342
340
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
48
48
48
Market Capitalization
170
160
185

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
284
291
300
Cash, Cash Equivalents & STI
82
152
159
Accounts Receivable, Net
86
88
92
Inventories
5
6
5
Total Current Liabilities
169
167
169
Payables & Accruals
- -
- -
- -
ST Debt
28
28
28
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.23%
7.44%
12.07%
Free Cash Flow
-19.87%
56.61%
42.2%
Net Income, GAAP
-25.91%
-22.46%
2.6%
Sales/Revenue/Turnover
3.54%
3.52%
4.77%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
185
183
190
191
749
2025
177
191
203
198
785
2026
187
199
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.03
0.04
0.3
0.21
0.52
2025
- -
0.2
0.32
0.01
0.54
2026
0.07
0.21
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.04
2026
- -
- -
- -
- -
- -
Business
Mediclin AG operates as a healthcare provider in Germany, specializing in professional medical services across acute care, post-acute rehabilitation, and inpatient nursing care segments. The company’s core offerings include acute medical care with a focus on neurology, neurological early rehabilitation, neurosurgery, psychosomatics, psychiatry, geriatrics, orthopedics, and internal medicine including cardiology, pneumology, and endocrinology. Additionally, Mediclin provides specialized treatments in tinnitus, cochlear implants, and addresses post- and long-COVID-19 conditions. Its services extend to outpatient and inpatient care delivered through a network of hospitals, rehabilitation clinics, nursing homes, and medical care centers across eleven federal states in Germany, operating approximately 8,200 beds and around 31 medical facilities. Founded in 1994 and headquartered in Offenburg, Germany, Mediclin also manages integrated care pathways that link acute and post-acute treatments to enhance the quality and efficiency of medical services. Recent developments include steady growth in its financial performance, achieving a 5.1% increase in consolidated group sales during the first nine months of 2025, and strategic operational moves such as the acquisition of the Robert Janker Klinik in Bonn and the renewal of lease agreements for 20 clinic locations. The company continues to focus on expanding its rehabilitation offerings and strengthening its service infrastructure while maintaining high standards in interdisciplinary medical care delivery. Mediclin’s comprehensive healthcare model targets a wide range of patient needs from acute illness treatment to long-term rehabilitation and nursing care services within the German healthcare system.